ATE533778T1 - Polynukleotide von haemophilus parasuis und anwendung davon - Google Patents

Polynukleotide von haemophilus parasuis und anwendung davon

Info

Publication number
ATE533778T1
ATE533778T1 AT06792087T AT06792087T ATE533778T1 AT E533778 T1 ATE533778 T1 AT E533778T1 AT 06792087 T AT06792087 T AT 06792087T AT 06792087 T AT06792087 T AT 06792087T AT E533778 T1 ATE533778 T1 AT E533778T1
Authority
AT
Austria
Prior art keywords
polynucleotides
parasuis
haemophilus parasuis
relates
polypeptides
Prior art date
Application number
AT06792087T
Other languages
English (en)
Inventor
Albert Bensaid
Pedrero Sonia Pina
Adan Raquel Rivas
Simone Oliveira
Maso Enric Espuna
Molina Carmen Herrero
Original Assignee
Fundacio Ct De Recerca En Sanitat Animal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Ct De Recerca En Sanitat Animal filed Critical Fundacio Ct De Recerca En Sanitat Animal
Application granted granted Critical
Publication of ATE533778T1 publication Critical patent/ATE533778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT06792087T 2005-09-21 2006-09-15 Polynukleotide von haemophilus parasuis und anwendung davon ATE533778T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200502296A ES2330904B1 (es) 2005-09-21 2005-09-21 Polinucleotidos de haemophilus parasuis y su uso.
PCT/EP2006/009006 WO2007039070A2 (en) 2005-09-21 2006-09-15 Polynucleotides of haemophilus parasuis and its use

Publications (1)

Publication Number Publication Date
ATE533778T1 true ATE533778T1 (de) 2011-12-15

Family

ID=37835264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06792087T ATE533778T1 (de) 2005-09-21 2006-09-15 Polynukleotide von haemophilus parasuis und anwendung davon

Country Status (8)

Country Link
US (1) US8350018B2 (de)
EP (1) EP1937712B1 (de)
AT (1) ATE533778T1 (de)
CA (1) CA2622635A1 (de)
DK (1) DK1937712T3 (de)
ES (2) ES2330904B1 (de)
TW (1) TW200806689A (de)
WO (1) WO2007039070A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
US9132183B2 (en) * 2007-03-09 2015-09-15 Newport Laboratories Modified live (JMSO strain) Haemophilus parasuis vaccine
CN105617373B (zh) * 2014-11-06 2019-07-09 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用
WO2020092769A2 (en) * 2018-10-31 2020-05-07 The University Of Massachusetts Silk nucleotides and proteins and methods of use
CN115820840A (zh) * 2022-11-23 2023-03-21 武汉轻工大学 一种副猪嗜血杆菌感染后引起仔猪免疫抑制的分子标记物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU554859B2 (en) 1981-09-04 1986-09-04 Regents Of The University Of California, The Polymerized albumin vaccine
WO1985004103A1 (en) 1984-03-09 1985-09-26 Scripps Clinic And Research Foundation Synthetic hepatitis b virus vaccine including both t cell anc b cell determinants
US5773249A (en) * 1986-11-04 1998-06-30 Protein Polymer Technologies, Inc. High molecular weight collagen-like protein polymers
US5580712A (en) * 1995-02-03 1996-12-03 Eastman Kodak Company Silver halide emulsions, elements and methods of making same using synthetic biopolymer peptizers
US5817303A (en) * 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
US20050142094A1 (en) * 2003-03-12 2005-06-30 Manoj Kumar Use of repeat sequence protein polymers in personal care compositions
WO2004094615A2 (en) * 2003-04-23 2004-11-04 The Texas A & M University System Prokaryotic collagen-like proteins and uses thereof
CA2524567A1 (en) * 2003-05-23 2004-12-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumors of glial origin

Also Published As

Publication number Publication date
US20100285070A1 (en) 2010-11-11
WO2007039070A3 (en) 2007-09-13
EP1937712B1 (de) 2011-11-16
WO2007039070A2 (en) 2007-04-12
ES2330904B1 (es) 2010-09-23
EP1937712A2 (de) 2008-07-02
US8350018B2 (en) 2013-01-08
ES2330904A1 (es) 2009-12-16
WO2007039070A8 (en) 2008-05-08
CA2622635A1 (en) 2007-04-12
DK1937712T3 (da) 2012-03-05
TW200806689A (en) 2008-02-01
ES2377569T3 (es) 2012-03-29

Similar Documents

Publication Publication Date Title
EP1731605A4 (de) Aus wt1 stammende krebsantigenpeptide
EA201301072A1 (ru) Антитела против il-23p19 и их применение
EP2493506A4 (de) Il-17a-antagonisten
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
MX2009010800A (es) Composiciones inmunogenicas que comprenden polipeptidos de mycobacterium tuberculosis y fusiones de los mismos.
UA94221C2 (en) Lipocalin protein
ATE476196T1 (de) Zusammensetzung zur auslösung, verbesserung und erhaltung von immunantworten gegen mhc-klasse-i- beschränkte epitope, für prophylaktische oder therapeutische zwecke
CY1108691T1 (el) Πολυπεπτιδια
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
PL1576967T3 (pl) Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne
DK1791571T3 (da) Radiofluorinerede peptider
WO2006112930A3 (en) Q3 sparc deletion mutant and uses thereof
DK1328547T3 (da) Identifikation og modifikation af immundominante epitoper i polypeptider
WO2008013954A3 (en) Tyrosine phosphorylation sites
WO2008054597A3 (en) Tyrosine phosphorylation sites
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
EA200702254A1 (ru) Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант
WO2008013934A8 (en) Tyrosine phosphorylation sites
ATE533778T1 (de) Polynukleotide von haemophilus parasuis und anwendung davon
PT1290160E (pt) Polipeptideos pellino humanos
EA200702193A1 (ru) Гликозилирование белков
SG160327A1 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
EP1961814A4 (de) Rekombinanter polyvalenter impfstoff
DE602004026284D1 (de) Hausstaubmilbenallergen